Topical corticosteroids market to reach $13.13 billion by 2030 at 7.4% CAGR, driven by rising incidence of chronic skin disorders.
Read MoreTopical antifungals market to reach $8.23 billion by 2030 at 6.4% CAGR, driven by increasing prevalence of skin diseases caused by environmental factors.
Read MoreTofacitinib market to reach $6.53 billion by 2030 at 14.0% CAGR, driven by increasing number of patients with inflammatory bowel disease.
Read MoreTnf alpha inhibitors market to reach $50.58 billion by 2030 at 3.0% CAGR, driven by increasing geriatric population susceptible to autoimmune disorders.
Read MoreTissue regeneration scaffold market to reach $5.58 billion by 2030 at 16.3% CAGR, driven by growing number of trauma cases from accidents and injuries.
Read MoreTissue plasminogen activator market to reach $5.66 billion by 2030 at 8.6% CAGR, driven by rising prevalence of lifestyle-related disorders.
Read MoreTissue engineering for wound care market to reach $13.61 billion by 2030 at 14.4% CAGR, driven by increasing prevalence of musculoskeletal disorders.
Read MoreTicagrelor market to reach $2.75 billion by 2030 at 7.3% CAGR, driven by increasing prevalence of cardiovascular diseases worldwide.
Read MoreTibsovo market to reach $1.7 billion by 2030 at 9.3% CAGR, driven by increasing prevalence of acute myeloid leukemia among aging populations.
Read MoreThyroid cancer drugs market to reach $2.39 billion by 2030 at 12.8% CAGR, driven by increasing incidences of thyroid cancer requiring advanced drug therapies.
Read More